Anzeige
Mehr »
Freitag, 24.04.2026 - Börsentäglich über 12.000 News
Während Miner kämpfen, entsteht in Finnland der vielleicht billigste Bitcoin Europas
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Zacks

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DoSkyWest (SKYW) Tops Q1 Earnings and Revenue Estimates
DoShore Bancshares (SHBI) Q1 Earnings and Revenues Beat Estimates
DoAre Options Traders Betting on a Big Move in American Healthcare REIT Stock?
DoIs the Options Market Predicting a Spike in AH REALTY TRUST Stock?
DoOnly 2 Stocks Driving Explosive Earnings Growth in 2026 - NVDA & AVGO
Do4 PEG-Driven GARP Picks for a Volatile Market in 2026
DoGlobe Life Q1 Earnings Miss Estimates, Rise Y/Y on Higher Premiums
DoMOH Q1 EPS Tops Estimates on Lower Medical Costs, Membership Declines
DoCisco Cashes in on AI Order Momentum: More Upside Ahead in 2026?
DoCOHR vs. ARM: Which Tech Growth Stock Offers More Upside Now?
DoSouthwest Airlines Q1 Earnings Meet Estimates, Revenue Beat
DoPLTR vs. SOFI: Which High-Growth Tech Stock is the Better Buy Now?
DoUiPath vs. AppLovin: Which AI-driven Tech Stock is Worth Considering?
DoDOCN Stock Jumps 104% YTD: Is There More Room to Grow?
DoSnap-on Q1 Earnings & Revenues Beat Estimates, Organic Sales Rise 3.4%
DoCSX Q1 Earnings Beat Estimates, Revenues Lag, 2026 View Raised
DoPackaging Corp. Q1 Earnings Beat Estimates on Pricing and Mix
DoRLI Q1 Earnings Miss Estimates, Investment Income Increases Y/Y
DoDover Q1 Earnings Beat Estimates, Rise Y/Y on Solid Demand
DoNasdaq Q1 Earnings & Revenues Beat Estimates, Dividend Raised
DoExxonMobil Awards Saipem $150M Contract for Longtail Development
DoSNY & REGN's Dupixent Wins FDA Nod for Pediatric Use in Urticaria
DoCBRE's Q1 Earnings Beat Estimates on Solid Leasing & Capital Markets
DoAXP Q1 Earnings Beat Estimates on Strong US Consumer Services Unit
DoAltimmune Catalysts: 2026 Data Readouts and Financing Risks